Enanta Pharmaceuticals Inc at JPMorgan Healthcare Conference Transcript
Okay. All right. We can get started. Good afternoon. I'm Eric Joseph, senior biotech analyst with JPMorgan, and our next presenting company is Enanta Pharmaceuticals. Presenting on behalf of the company is CEO, Jay Luly. And I just want to -- one program you note there's going to be a Q&A after the presentation. (Operator Instructions) So with that, Jay. Thank you.
Thanks, Eric, and thank you very much for the opportunity to present again this year. Before I begin, I want to remind you, I'll be making some forward-looking statements. And for a summary, the risk associated with these statements, please see our filings on sec.gov and on our website. For those of you who are less familiar with Enanta, we are a virology-focused company, working on a number of different important viruses. A lot of them are in the respiratory category, respiratory viruses like RSV and COVID. We are also working on
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
